Alpha-blockade during congenital heart surgery admissions: analysis from national database.
Brian LeeEnrique G VillarrealEmad B MossadJacqueline RausaRonald A BronickiSaúl FloresRohit S LoombaPublished in: Cardiology in the young (2021)
Alpha-blockade is used in a subset of paediatric cardiac surgeries and is independently associated with significant reductions in ICU length of stay, hospital length of stay, and mortality without significantly altering billed charges.
Keyphrases
- intensive care unit
- minimally invasive
- adverse drug
- coronary artery bypass
- emergency department
- healthcare
- cardiovascular events
- left ventricular
- quality improvement
- mechanical ventilation
- risk factors
- heart failure
- type diabetes
- coronary artery disease
- cardiovascular disease
- surgical site infection
- electronic health record
- extracorporeal membrane oxygenation